1. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review.Crit Care Med.2001;29:2264–2270.
2.
2. Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit: a systematic review and consensus statement.Clin Nutrition.2003;22:221–233.
3.
3. Zaloga GP. Immune-enhancing enteral diets: where's the beef?Crit Care Med.1998;26:1143–1146.
4.
4. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials.Ann Surg.1999;229:467–477.
5.
5. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome.Crit Care Med.1999;27:2799–2805.
6.
6. Martindale RG, Cresci G. Preventing infectious complications with nutritional intervention.JPEN J Parenter Enteral Nutr.2005;29(Suppl):S53–S56.
7.
7. Farber MS, Moses J, Korn M. Reducing costs and patient morbidity in the enterally fed ICU patient.JPEN J Parenter Enteral Nutr.2005;29(Suppl)S62–S69.
8.
8. Braga M, Gianotti L. Preoperative immunonutrition: cost-benefit analysis.JPEN J Parenter Enteral Nutr.2005;29(Suppl):S57–S61.
9.
9. Strickland A, Brogan A, Krauss J, Martindale K, Cresci G. Is the use of immune modulating formulas a cost effective nutritional strategy: a national database evaluation.JPEN J Parenter Enteral Nutr.2005;29(Suppl):S81–S91.
10.
10. Bansal V, Syres KM, Makarenkova V, et al. Interactions between fatty acids and arginine metabolism: implications for the design of immune enhancing diets.JPEN J Parenter Enteral Nutr.2005; 29(Suppl):S75–S80.
11.
11. Zaloga GP, Siddiqui R, Terry C, Marik PE. Arginine: mediator or modulator of sepsis.Nutr Clin Pract.2004;19:201–215.
12.
12. Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation?Nutr Clin Pract.2004;19:216–225.
13.
13. Heyland DK, Samis A. Does immunonutrition in patients with sepsis do more harm than good?Intensive Care Med.2003;29:669–671.
14.
14. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.JAMA.2001;286:944–953.
15.
15. Luiking YC, Poeze M, Ramsay G, Deutz NEP. The role of argi-nine in infection and sepsis.JPEN J Parenter Enteral Nutr.2005;29(Suppl):S70–S74.
16.
16. Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients.Crit Care Med.2000;28:643–648.
17.
17. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized clinical trial.Crit Care Med.1995;23:436–449.
18.
18. Atkinson S, Sieffert E, Bihari D. A prospective randomized double blind controlled clinical trial of enteral immunonutrition in the critically ill.Crit Care Med.1996;26:1164–1172.
19.
19. Caparros T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high protein diet enriched with arginine, fiber, and antioxidants compared with a standard high protein diet: the effect on nosocomial infections and outcome.JPEN J Par-enter Enteral Nutr.2001;25:299–309.
20.
20. Bertolini G, Iapichino G, Radrizzani D, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicenter clinical trial.Int Care Med.2003;29:834–840.
21.
21. Kris-Etherton PM, Harris WS, Appel LJ, for the AHANutrition Committee. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association.Arterioscler Thromb Vasc Biol.2003;23:151–152.
22.
22. Cresci G. Targeting the use of specialized nutritional formulas in surgery and critical care.JPEN J Parenter Enteral Nutr.2005;29(Suppl):S92–S95.
